EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Silybin Cocrystals with Improved Solubility and Bioavailability

Bingqing Zhu, Zhenfeng Ding, Xiaoyi Rong, Shengqiang Li, Xuefeng Mei

Pharmaceuticals · 13.01.2025 · 18 (1) · 90

DOI: 10.3390/ph18010090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 13.01.2025. Verfasst von Bingqing Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Analytical & Solid-State Chemistry Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi …. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgroud/Objectives: Silymarin, an extract from milk thistle, is widely recognized for its therapeutic potential in treating liver disorders. However, its clinical utility is limited by the poor solubility and low bioavailability of its key active ingredient, Silybin. In this study, we sought to address this issue through the development of a novel cocrystal of Silyin.

Methods

Silybin-L-proline cocrystal was synthesized and the physicochemical properties of the cocrystal were characterized by PXRD, TGA, DSC, and FTIR. Dissolution tests were conducted in various pH solutions, and the impact of precipitation inhibitors was evaluated. Furthermore, pharmacokinetic study in rats were performed to assess the bioavailability.

Results

The dissolution studies demonstrated that the cocrystal has a significant improvement in dissolution performance, particularly in acidic environments. Furthermore, the use of precipitation inhibitors, such as PVP, prolonged the supersaturation period for adequate absorption. Pharmacokinetic studies in rats revealed that the cocrystal exhibited a 16-fold increase in bioavailability compared to the raw Silybin extract, outperforming the commercial Silybin–phosphatidylcholine complex.

Conclusions

The Silybin–L-proline cocrystal significantly enhances dissolution and bioavailability, indicating its potential to improve the therapeutic efficacy of Silybin in clinical applications.

Schlagwörter

Stichwörter der Autor:innen

L-prolinebioavailabilitycocrystalsilybinsolubility

Autor:innen und Institutionen

  • Pharmaceutical Analytical & Solid-State Chemistry Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.

Zitieren

APA

Zhu, B., Ding, Z., Rong, X., Li, S., & Mei, X. (2025). Silybin Cocrystals with Improved Solubility and Bioavailability. Pharmaceuticals, 18(1), 90. https://doi.org/10.3390/ph18010090

Vancouver

Zhu B, Ding Z, Rong X, Li S, Mei X. Silybin Cocrystals with Improved Solubility and Bioavailability. Pharmaceuticals. 2025;18(1):90. doi:10.3390/ph18010090

BibTeX
@article{Zhu2025,
  author = {Zhu, Bingqing and Ding, Zhenfeng and Rong, Xiaoyi and Li, Shengqiang and Mei, Xuefeng},
  title = {Silybin Cocrystals with Improved Solubility and Bioavailability},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {90},
  doi = {10.3390/ph18010090}
}
Kostenlos starten →